Mental illness and psycotropic drugs

Mental Illness: Insane Profits, Lifelong Customers, and Why the Church Should Be Talking About It

On July 24, 1972, biochemist David Wong identified a chemical he called “Lilly 110140,” which was effective in treating mental illness while avoiding the risks associated with the earlier drugs. The experimental drug made by the partnership of Wong, Ray Fuller, and Bryan Molloy was later dubbed Fluoxetine, and in December of

Continue readingMental Illness: Insane Profits, Lifelong Customers, and Why the Church Should Be Talking About It